Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 17

Results For "Gujarat"

168 News Found

Mangalam Drugs commissions intermediate manufacturing facility
News | June 19, 2021

Mangalam Drugs commissions intermediate manufacturing facility

This will enable Mangalam to reduce its reliability on Chinese imports for this product and also help to maintain an uninterrupted supply chain to a great extent


Bharat Biotech signs MoU with GCVC for COVID Vaccine
News | May 28, 2021

Bharat Biotech signs MoU with GCVC for COVID Vaccine

It is expected that the drug substance would be available from August 2021 which will be supplied back to Bharat Biotech for producing COVAXIN


Five manufacturers get license to produce Black Fungus drug
News | May 23, 2021

Five manufacturers get license to produce Black Fungus drug

NATCO Pharmaceuticals, Hyderabad; Alembic Pharmaceuticals, Vadodara; Gufic Biosciences Ltd., Gujarat; Emcure Pharmaceuticals, Pune; and Lyka, Gujarat are new manufacturers


Bharat Biotech ramping up manufacturing capacity to 70 Cr doses: Dr. Raches Ella
People | May 23, 2021

Bharat Biotech ramping up manufacturing capacity to 70 Cr doses: Dr. Raches Ella

We focused on developing the product last year but now our focus is on ramping up our manufacturing capacity


India's first indigenous COVID-19 RT-PCR testing kit approved
News | May 21, 2021

India's first indigenous COVID-19 RT-PCR testing kit approved

This kit was developed in partnership with Gujarat-based LabCare Diagnostics. LabCare is into clinical chemistry reagents, serology tests, immuno-chromatographic tests and urine analysis strips


Govt. to augment Covaxin production by 10 crore doses
News | May 16, 2021

Govt. to augment Covaxin production by 10 crore doses

Financial support is being provided as a grant from the Government of India


DCGI approves anti-COVID drug developed by DRDO
Policy | May 10, 2021

DCGI approves anti-COVID drug developed by DRDO

The drug accumulates in the virus infected cells and prevents virus growth by stopping viral synthesis and energy production


COVID-19 drug Remdesivir now priced at Rs. 899
News | March 25, 2021

COVID-19 drug Remdesivir now priced at Rs. 899

Zydus has made its brand of Remdesivir, Remdac more affordable at Rs. 899 for a 100 mg lyophilized injection.